Patent · US Expired

C-21 modified epothilones

US6262094A · kind A · utility

64Cited by

0References

29Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Gerhard Hoefle · Braunschweig, DE
Nicole Glaser · Braunschweig, DE
Thomas Leibold · Braunschweig, DE
Gregory D. Vite · Titusville, US
Soong-Hoon Kim · Titusville, US

Key dates

Filing date	Feb 17, 2000
Grant date	Jul 17, 2001
Priority date	—
Expiry date	Feb 17, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with epothilones in which the thiazole substituent has been modified, with methods for their preparation and with antifungal or therapeutic agents which contain these epothilones.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.